Two Sigma Securities’s Larimar Therapeutics LRMR Stock Holding History

Two Sigma Securities’s Portfolio LRMR Stock Details LRMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,400	Closed	-$46.8K	–	2102
2026 Q1	$46.8K	Sell	10,400 -1,992	-16%	-$7.96K	0.01%	1275
2025 Q4	$47.2K	Buy	+12,392	New	+$48.2K	0.01%	1073
2022 Q4	–	Sell	-11,477	Closed	-$37K	–	2978
2022 Q3	$37K	Buy	+11,477	New	+$28.8K	﹤0.01%	2222
2019 Q3	–	Sell	-967	Closed	-$14K	–	2284
2019 Q2	$14K	Buy	+967	New	+$25.8K	﹤0.01%	1974
2016 Q3	–	Sell	-1,155	Closed	-$83K	–	739
2016 Q2	$83K	Buy	+1,155	New	+$91.3K	0.05%	322

Other funds holding LRMR

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return

Two Sigma Securities's LRMR Position: Q2 2026 in Review

Two Sigma Securities sold out of Larimar Therapeutics (LRMR) in Q2 2026, closing a stake of 10,400 shares — an estimated $46.8K sold.

Two Sigma Securities first reported a position in LRMR in Q2 2016 and held it in 5 quarters. The position peaked at $83K in Q2 2016. 163 funds tracked by Wall St. Rank hold LRMR as of Q2 2026.

Two Sigma Securities reported no remaining Larimar Therapeutics position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 10,400 Larimar Therapeutics shares in Q2 2026, an estimated $46.8K.
Two Sigma Securities first reported a position in Larimar Therapeutics in Q2 2016 and held it in 5 quarters.
Two Sigma Securities's Larimar Therapeutics position peaked at $83K in Q2 2016.
163 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.